Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Amortizatization of Intangibles (2017 - 2020)

Historic Amortizatization of Intangibles for vTv Therapeutics (VTVT) over the last 4 years, with Q4 2020 value amounting to $40000.0.

  • vTv Therapeutics' Amortizatization of Intangibles fell 5121.95% to $40000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $380000.0, marking a year-over-year decrease of 2857.14%. This contributed to the annual value of $380000.0 for FY2020, which is 2857.14% down from last year.
  • vTv Therapeutics' Amortizatization of Intangibles amounted to $40000.0 in Q4 2020, which was down 5121.95% from $158000.0 recorded in Q3 2020.
  • In the past 5 years, vTv Therapeutics' Amortizatization of Intangibles ranged from a high of $276000.0 in Q2 2017 and a low of $40000.0 during Q4 2020
  • Moreover, its 4-year median value for Amortizatization of Intangibles was $194000.0 (2017), whereas its average is $184687.5.
  • Data for vTv Therapeutics' Amortizatization of Intangibles shows a peak YoY increase of 3739.13% (in 2020) and a maximum YoY decrease of 7459.46% (in 2020) over the last 5 years.
  • Quarter analysis of 4 years shows vTv Therapeutics' Amortizatization of Intangibles stood at $276000.0 in 2017, then decreased by 20.65% to $219000.0 in 2018, then tumbled by 62.56% to $82000.0 in 2019, then plummeted by 51.22% to $40000.0 in 2020.
  • Its last three reported values are $40000.0 in Q4 2020, $158000.0 for Q3 2020, and $135000.0 during Q2 2020.